AHR and neoplasm: At the same time, tumor cells drive up-regulation of PD-1 expression on CTLs through transcellular kynurenine (Kyn)-aryl hydrocarbon receptor (AhR) pathway.[21] PD-1 and PD-L1 are negative immunoregulatory factors.